Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ellis-van Creveld syndrome protein 2 (EVC2) is a transmembrane protein that forms a heterodimeric complex with EVC protein and plays a crucial role in regulating Hedgehog signaling from within primary cilia[1][2]. EVC2 specifically localizes to the EvC zone, a specialized ciliary region located immediately distal to the transition zone of primary cilia[1][3]. The protein is essential for proper skeletal development and chondrogenesis, as mutations in EVC2 cause Ellis-van Creveld syndrome and Weyers acrofacial dysostosis, two rare genetic ciliopathies characterized by chondrodysplastic dwarfism and abnormalities in oral cavity development[1][2]. EVC2 contains a Weyers-deleted peptide (W-peptide) that is critical for proper ciliary targeting through interaction with the EFCAB7-IQCE complex via two essential motifs: the FV motif and the RRKKN motif[1]. The protein undergoes post-translational modifications including ubiquitination and sumoylation that regulate its stability and ciliary localization[1]. EVC2 is expressed in growth plate cartilage, perichondrium, ossified tissues, and muscles, and its dysfunction leads to reduced Hedgehog signaling activity and subsequent skeletal defects[2]. The protein's ciliary localization is mutually dependent on EVC protein, and loss of either component results in failure of the complex to properly localize to cilia and impaired Hedgehog signaling[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ellis-van Creveld syndrome protein 2 (EVC2).